Similarly, antioxidant compounds, such as butein, genistein, tea polyphenols, and pyrrolidine dithiocarbamate, can suppress breast and prostate cancer cell growth via ROS level reduction [67], GPx activation [68], and survivin inhibition [69, 70]. Here, BIRC5 is linked to prostate carcinoma.